<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="prognosis in patients with COVID-19, emphasizing the importance of precocious" exact="detection" post="and implementation of optimal therapeutic strategies. Subject terms Cardiovascular"/>
 <result pre="or intestinal infections in humans and animals [2]. The SARS-CoV-2" exact="infection" post="occurs through the coupling of S-protein located on the"/>
 <result pre="or not related to the cardiovascular complications associated with SARS-CoV-2" exact="infection" post="were excluded from the revision. Articles that were not"/>
 <result pre="patients with the worst evolution are the elderly, where the" exact="prevalence" post="of hypertension and diabetes is higher. Hypertension, as a"/>
 <result pre="a higher risk of developing severe disease due to SARS-CoV-2" exact="infection" post="[7]. A retrospective cohort study included 126 patients with"/>
 <result pre="COVID-19 without hypertension. Among hypertensives, 21.3% had more severe SARS-CoV-2" exact="infection" post="and higher death rate, 10.3% vs. 6.4%, when compared"/>
 <result pre="presented a less profound inflammatory profile when compared with non-ARBs/ACEi" exact="treatment" post="[8]. Hypertension seems to enhance the inflammatory profile in"/>
 <result pre="between myocardial injury and inflammatory hyperactivity triggered by the viral" exact="infection" post="[10]. The pathophysiology regarding myocardial damage caused by COVID-19"/>
 <result pre="infection [10]. The pathophysiology regarding myocardial damage caused by COVID-19" exact="infection" post="is not completely elucidated. However, studies highlight that the"/>
 <result pre="COVID-19. Thus, it isÂ imperative the implementation of a thorough" exact="screening" post="through dosage of troponin,Â ECG, and bedside echocardiography, mainly"/>
 <result pre="are many studies correlating acute myocardial injury (AMI) and the" exact="infection" post="by SARS-CoV-2 [10, 16]. According to the Fourth Universal"/>
 <result pre="cardiomyopathy Takotsubo cardiomyopathy and its reverse presentation are important differential" exact="diagnosis" post="of myocardial injury. So far, there are some very"/>
 <result pre="infection, but by the profound emotional stress caused by the" exact="isolation" post="period leading to an excessive release of catecholamines [19]."/>
 <result pre="release of catecholamines [19]. Venous thromboembolism There is evidence that" exact="infection" post="by COVID-19 predisposes to a prothrombotic state by direct"/>
 <result pre="(DVT) and pulmonary thromboembolism (PTE) described in patients with severe" exact="infection" post="by SARS-CoV-2 [20]. This pathophysiological mechanism is supported by"/>
 <result pre="coagulopathy scoreâ€‰â‰¥â€‰4 (32.8% vs. 52.4%, pâ€‰=â€‰0.017) [21]. Thus, the anticoagulant" exact="treatment" post="in patients with severe COVID-19 based on serum D-dimer"/>
 <result pre="interval prolongation and no clinical benefit was observed with lopinavir/ritonavir" exact="treatment" post="beyond standard care [20]. Furthermore, lopinavir/ritonavir can affect anticoagulant"/>
 <result pre="these drugs are among the most commonly prescribed for the" exact="treatment" post="of hypertension, diabetes, and heart failure worldwide, clinical conditions"/>
 <result pre="of RAAS inhibitors, which would potentially increase the susceptibility to" exact="infection" post="by SARS-CoV-2. In animal models, the use of these"/>
 <result pre="study with 12,594 individuals evaluating the relation between previous hypertension" exact="treatment" post="with ACEi, ARBs, Î²-blockers, calcium-channel blockers, or thiazide diuretics"/>
 <result pre="between the use of these drugs and more severe SARS-CoV-2" exact="infection" post="was demonstrated [33]. Therefore, ACEi/ARBs are possibly potential drugs"/>
 <result pre="demonstrated [33]. Therefore, ACEi/ARBs are possibly potential drugs for COVID-19" exact="treatment" post="in patients with pre-existing hypertension, due to their capacity"/>
 <result pre="more favorable outcomes. Conclusion Hypertension is strongly associated with SARS-CoV-2" exact="infection" post="possibly due to the proinflammatory state of this chronic"/>
 <result pre="mainly evidenced through retrospective studies, emphasizing the importance of early" exact="detection" post="and implementation of a proper therapy. Publisherâ€™s note Springer"/>
 <result pre="coronavirus disease 2019 (COVID-19) outbreak in ChinaJAMA202032312394210.1001/jama.2020.2648 4.YeQWangBMaoJThe pathogenesis and" exact="treatment" post="of the â€˜Cytokine Stormâ€² in COVID-19J Infect2020806071310.1016/j.jinf.2020.03.03732283152 5.RichardsonSHirschJSNarasimhanMCrawfordJMMcGinnTDavidsonKWet al.Presenting"/>
 <result pre="Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for" exact="diagnosis" post="and management. Heart Rhythm. 2020;S1547-5271:30422â€&quot;7. 20.BikdeliBMadhavanMVJimenezDChuichTDreyfusIDrigginEet al.COVID-19 and thrombotic"/>
 <result pre="for prevention, antithrombotic therapy, and follow-upJ Am Coll Cardiol20207529507310.1016/j.jacc.2020.04.03132311448 21.TangNBaiHChenXGongJLiDSunZAnticoagulant" exact="treatment" post="is associated with decreased mortality in severe coronavirus disease"/>
 <result pre="of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients" exact="testing" post="positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;e201834."/>
</results>
